Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127843751 | 12784375 | 1 | I | 20030125 | 20030225 | 20160927 | 20160927 | EXP | CH-ZLB_BIOPLASMA_AG-RED/03/03/SCH | CSL BEHRING | 77.00 | YR | E | F | Y | 54.00000 | KG | 20160927 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127843751 | 12784375 | 1 | PS | IVIG lyophilized | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | DAILY DOSE QUANTITY: 18, DAILY DOSE UNIT: G | Y | 102367 | INFUSION | ||||||||
| 127843751 | 12784375 | 2 | SS | IVIG lyophilized | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | DAILY DOSE QUANTITY: 18, DAILY DOSE UNIT: G | Y | 102367 | INFUSION | ||||||||
| 127843751 | 12784375 | 3 | SS | ALKERAN | MELPHALAN | 1 | Oral | DAILY DOSE QUANTITY: 10, DAILY DOSE UNIT: MG | 0 | ||||||||||
| 127843751 | 12784375 | 4 | C | BELOC ZOC | 2 | Oral | DAILY DOSE QUANTITY: 50, DAILY DOSE UNIT: MG | 0 | |||||||||||
| 127843751 | 12784375 | 5 | C | MARCOUMAR | PHENPROCOUMON | 1 | Oral | 0 | |||||||||||
| 127843751 | 12784375 | 6 | C | TOREM | TORSEMIDE | 1 | Oral | 0 | |||||||||||
| 127843751 | 12784375 | 7 | C | TOREM | TORSEMIDE | 1 | 0 | ||||||||||||
| 127843751 | 12784375 | 8 | C | COSAAR | LOSARTAN POTASSIUM | 1 | Oral | DAILY DOSE QUANTITY: 50, DAILY DOSE UNIT: MG | 0 | ||||||||||
| 127843751 | 12784375 | 9 | C | ZAROXOLYN | METOLAZONE | 1 | Oral | DAILY DOSE QUANTITY: 2.5, DAILY DOSE UNIT: MG | 0 | ||||||||||
| 127843751 | 12784375 | 10 | C | ZAROXOLYN | METOLAZONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127843751 | 12784375 | 1 | Plasma cell myeloma |
| 127843751 | 12784375 | 3 | Plasma cell myeloma |
| 127843751 | 12784375 | 4 | Essential hypertension |
| 127843751 | 12784375 | 6 | Essential hypertension |
| 127843751 | 12784375 | 7 | Chronic kidney disease |
| 127843751 | 12784375 | 8 | Essential hypertension |
| 127843751 | 12784375 | 9 | Essential hypertension |
| 127843751 | 12784375 | 10 | Chronic kidney disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127843751 | 12784375 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127843751 | 12784375 | Anuria | |
| 127843751 | 12784375 | Blood creatinine increased | Blood creatinine increased |
| 127843751 | 12784375 | Diarrhoea | |
| 127843751 | 12784375 | Oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127843751 | 12784375 | 1 | 20021129 | 20021129 | 0 | |
| 127843751 | 12784375 | 2 | 20030120 | 20030120 | 0 | |
| 127843751 | 12784375 | 3 | 20030120 | 20030121 | 0 |